Pharmaceutical

Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants

Sanofi has commenced the shipping of BEYFORTUS to the US for healthcare providers and the Vaccines for Children programme.

Sep 18, 2024 - 04:00
Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants
Sanofi has commenced the shipping of BEYFORTUS to the US for healthcare providers and the Vaccines for Children programme.
Read the original article

Tags:

Previous Article

MaxCyte and Kamau Therapeutics sign platform license agreement

Next Article

SBTi approves Piramal Pharma’s GHG reduction targets

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to $2.2 billion as it seeks to bolster pipeline

STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to ...

Jan 24, 2024

STAT+: DOJ investigating Community Health Systems’ hospitals

STAT+: DOJ investigating Community Health Systems’ hosp...

Feb 23, 2024

Here’s a new data point for cancer patients to consider: ‘time toxicity’

Here’s a new data point for cancer patients to consider...

Apr 11, 2023